Medlive Technology Co., Ltd.
Sümbol: 2192.HK
HKSE
8.51
HKDTuruhind täna
23.3856
P/E suhe
-0.5721
PEG suhe
6.19B
MRK Cap
- 0.02%
DIV tootlus
Medlive Technology Co., Ltd. (2192-HK) Finantsaruanded
Bilanss
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |||
---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 17632.85 | 4400.9 | 4216.9 | 3908.7 | ||||||
balance-sheet.row.short-term-investments | 127.15 | 42.6 | 29.6 | 29.6 | ||||||
balance-sheet.row.net-receivables | 581.29 | 155.9 | 124.2 | 95.9 | ||||||
balance-sheet.row.inventory | 0.62 | 0.1 | 0.2 | 0.1 | ||||||
balance-sheet.row.other-current-assets | 229.63 | 58.3 | 35.4 | 33 | ||||||
balance-sheet.row.total-current-assets | 18279.8 | 4572.6 | 4351.7 | 4013 | ||||||
balance-sheet.row.property-plant-equipment-net | 45.37 | 11.1 | 14.6 | 16.9 | ||||||
balance-sheet.row.goodwill | 726.41 | 192.5 | 111.5 | 69.7 | ||||||
balance-sheet.row.intangible-assets | 152.99 | 66.7 | 24.3 | 9.3 | ||||||
balance-sheet.row.goodwill-and-intangible-assets | 879.4 | 259.3 | 135.9 | 79 | ||||||
balance-sheet.row.long-term-investments | 233.75 | 42.4 | 63.2 | -29.3 | ||||||
balance-sheet.row.tax-assets | 17.98 | 8.5 | 8.3 | 6.3 | ||||||
balance-sheet.row.other-non-current-assets | 96.83 | 0 | 29.6 | 29.6 | ||||||
balance-sheet.row.total-non-current-assets | 1273.32 | 321.2 | 251.5 | 102.6 | ||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.total-assets | 19553.12 | 4893.8 | 4603.2 | 4115.6 | ||||||
balance-sheet.row.account-payables | 36.9 | 14.8 | 2.7 | 6.2 | ||||||
balance-sheet.row.short-term-debt | 8.87 | 4.5 | 5.1 | 4.2 | ||||||
balance-sheet.row.tax-payables | 46.5 | 25.7 | 35.2 | 31.6 | ||||||
balance-sheet.row.long-term-debt-total | 15.72 | 3.6 | 6.1 | 9 | ||||||
Deferred Revenue Non Current | -7.54 | -7.5 | 0 | 0 | ||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 10.66 | - | - | - | ||||||
balance-sheet.row.other-current-liab | 770 | 175 | 124.9 | 102.8 | ||||||
balance-sheet.row.total-non-current-liabilities | 168.82 | 58.8 | 38.6 | 30.2 | ||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.capital-lease-obligations | 33.45 | 8.2 | 11.3 | 13.2 | ||||||
balance-sheet.row.total-liab | 980.04 | 248.6 | 171.3 | 143.4 | ||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 39 | ||||||
balance-sheet.row.common-stock | 0.18 | 0 | 0 | 0 | ||||||
balance-sheet.row.retained-earnings | 1070.8 | 284.9 | 175.3 | 75.6 | ||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 5901.59 | 4597.3 | 308.1 | -39 | ||||||
balance-sheet.row.other-total-stockholders-equity | 11434.72 | -284.9 | 3917.6 | 3873 | ||||||
balance-sheet.row.total-stockholders-equity | 18407.29 | 4597.4 | 4401 | 3948.7 | ||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 19553.12 | 4893.8 | 4603.2 | 4115.6 | ||||||
balance-sheet.row.minority-interest | 165.8 | 47.8 | 30.9 | 23.5 | ||||||
balance-sheet.row.total-equity | 18573.09 | 4645.2 | 4431.9 | 3972.2 | ||||||
balance-sheet.row.total-liabilities-and-total-equity | 19553.12 | - | - | - | ||||||
Total Investments | 318.26 | 42.4 | 92.8 | 0.3 | ||||||
balance-sheet.row.total-debt | 24.58 | 8.2 | 11.3 | 13.2 | ||||||
balance-sheet.row.net-debt | -17438.47 | -4350.1 | -4176 | -3865.9 |
Rahavoogude aruanne
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |||
---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 242.3 | 242.3 | 135 | 69.9 | ||||||
cash-flows.row.depreciation-and-amortization | 9.21 | 0 | 9 | 6.1 | ||||||
cash-flows.row.deferred-income-tax | -19.3 | 0 | 0 | -13.7 | ||||||
cash-flows.row.stock-based-compensation | 10.41 | 10.4 | 17.2 | 14.3 | ||||||
cash-flows.row.change-in-working-capital | 15.77 | 0 | -9.6 | -27.9 | ||||||
cash-flows.row.account-receivables | -16.32 | 0 | -25.1 | -31.7 | ||||||
cash-flows.row.inventory | 0.1 | 0 | -0.1 | -0.1 | ||||||
cash-flows.row.account-payables | 0.17 | 0 | 25.1 | 31.7 | ||||||
cash-flows.row.other-working-capital | 31.98 | 0 | -9.5 | -27.8 | ||||||
cash-flows.row.other-non-cash-items | -175.83 | -252.7 | -74.5 | -4.4 | ||||||
cash-flows.row.net-cash-provided-by-operating-activities | 101.87 | 0 | 0 | 0 | ||||||
cash-flows.row.investments-in-property-plant-an-equipment | -0.75 | 0 | -7.5 | -2 | ||||||
cash-flows.row.acquisitions-net | -56.39 | 0 | -42.6 | -53 | ||||||
cash-flows.row.purchases-of-investments | -5.65 | 0 | -3579.7 | -5.3 | ||||||
cash-flows.row.sales-maturities-of-investments | 1.58 | 0 | 0.7 | 5.3 | ||||||
cash-flows.row.other-investing-activites | -577.8 | 0 | 43.5 | 4.4 | ||||||
cash-flows.row.net-cash-used-for-investing-activites | -634.95 | 0 | -3585.6 | -50.5 | ||||||
cash-flows.row.debt-repayment | 0 | 0 | -5 | -6.5 | ||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 4033.1 | ||||||
cash-flows.row.common-stock-repurchased | -0.68 | 0 | 5 | 0 | ||||||
cash-flows.row.dividends-paid | -124.69 | 0 | -12.1 | -92 | ||||||
cash-flows.row.other-financing-activites | -7.76 | 0 | -10.2 | -142.6 | ||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -133.13 | 0 | -22.4 | 3792.1 | ||||||
cash-flows.row.effect-of-forex-changes-on-cash | 63.06 | 0 | 329.9 | -53.9 | ||||||
cash-flows.row.net-change-in-cash | 1308.37 | 0 | -3200.9 | 3732 | ||||||
cash-flows.row.cash-at-end-of-period | 6009.58 | 678.2 | 678.2 | 3879.1 | ||||||
cash-flows.row.cash-at-beginning-of-period | 4701.21 | 678.2 | 3879.1 | 147.1 | ||||||
cash-flows.row.operating-cash-flow | 101.87 | 0 | 77.2 | 44.4 | ||||||
cash-flows.row.capital-expenditure | -0.75 | 0 | -7.5 | -2 | ||||||
cash-flows.row.free-cash-flow | 101.12 | 0 | 69.7 | 42.5 |
Kasumiaruande rida
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |||
---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 412 | 412 | 314.1 | 284.4 | ||||||
income-statement-row.row.cost-of-revenue | 160.67 | 160.7 | 101.3 | 83.7 | ||||||
income-statement-row.row.gross-profit | 251.34 | 251.3 | 212.7 | 200.7 | ||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||
income-statement-row.row.research-development | 54.26 | - | - | - | ||||||
income-statement-row.row.selling-general-administrative | 141.3 | - | - | - | ||||||
income-statement-row.row.selling-and-marketing-expenses | 32.78 | - | - | - | ||||||
income-statement-row.row.other-expenses | 0 | -8.9 | -8 | -0.7 | ||||||
income-statement-row.row.operating-expenses | 182.51 | 173.6 | 143.4 | 126.9 | ||||||
income-statement-row.row.cost-and-expenses | 343.18 | 334.2 | 244.7 | 210.7 | ||||||
income-statement-row.row.interest-income | 184.31 | 183.9 | 66.2 | 7.7 | ||||||
income-statement-row.row.interest-expense | 0.22 | 0.4 | 0.5 | 0.5 | ||||||
income-statement-row.row.selling-and-marketing-expenses | 32.78 | - | - | - | ||||||
income-statement-row.row.total-other-income-expensenet | 188 | 188.1 | 0.2 | -0.4 | ||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||
income-statement-row.row.other-operating-expenses | 0 | -8.9 | -8 | -0.7 | ||||||
income-statement-row.row.total-operating-expenses | 188 | 188.1 | 0.2 | -0.4 | ||||||
income-statement-row.row.interest-expense | 0.22 | 0.4 | 0.5 | 0.5 | ||||||
income-statement-row.row.depreciation-and-amortization | 3.91 | 9.4 | 9 | 6.1 | ||||||
income-statement-row.row.ebitda-caps | 69.05 | - | - | - | ||||||
income-statement-row.row.operating-income | 65.14 | 65 | 134.8 | 70.3 | ||||||
income-statement-row.row.income-before-tax | 253.13 | 253.1 | 135 | 69.9 | ||||||
income-statement-row.row.income-tax-expense | 1.37 | 1.4 | 8.6 | 24.7 | ||||||
income-statement-row.row.net-income | 242.3 | 242.3 | 117.3 | 40.6 |
Korduma kippuv küsimus
Mis on Medlive Technology Co., Ltd. (2192.HK) koguvara?
Medlive Technology Co., Ltd. (2192.HK) koguvara on 4893816000.000.
Mis on ettevõtte aastane tulu?
Aastane tulu on 238498000.000.
Mis on ettevõtte kasumimarginaal?
Ettevõtte kasumimarginaal on 0.610.
Mis on ettevõtte vaba rahavoog?
Vaba rahavoog on 0.138.
Mis on ettevõtte puhaskasumimarginaal?
Puhaskasumimarginaal on 0.588.
Mis on ettevõtte kogutulu?
Kogutulu on 0.158.
Mis on Medlive Technology Co., Ltd. (2192.HK) puhaskasum (puhaskasum)?
Puhaskasum (netotulu) on 242301000.000.
Kui suur on ettevõtte koguvõlg?
Koguvõlg on 8192000.000.
Mis on tegevuskulude arv?
Tegevuskulud on 173579000.000.
Milline on ettevõtte rahaline näitaja?
Ettevõtte raha on 4358255000.000.